A clinical trial to assess efficacy and safety of a fixed dose combination of meropenam and sulbactam in lower respiratory tract infection caused by Gm (-ve) organisms including Pseudomonas aeruginosa.

Authors
Category Primary study
Registry of TrialsClinical Trials Registry - India
Year 2010
This article has no abstract
Epistemonikos ID: 6d24131b42fec05639859a3623a30e0ca0ef25d2
First added on: Apr 16, 2025